PROM1 and cancer: CD133 protein was later reported as a marker of poor prognosis within cancers (e.g. colorectal/breast cancer and myeloid leukemia) and was subsequently confirmed as being specifically expressed by the CSC population [3, 11, 12, 13, 14].